Skip to main content
Institutional

The director of the CiMUS of the USC, Mabel Loza, joins the prestigious Royal National Academy of Pharmacy.

The scientific director of CiMUS and Professor of Pharmacology at the University of Santiago de Compostela (USC), Mabel Loza, was sworn in as a Corresponding Academician of the Royal National Academy of Pharmacy, with a speech entitled "Pharmacology and drug discovery for a new era". The Laudatio was given by Juan Tamargo Menéndez, Full Academician and president of Section 4. 

Professional career focused on innovation and transfer.

Professor of Pharmacology at the USC, she studied pharmacy at the University of Santiago and completed her doctoral thesis in the Department of Pharmacology at the Faculty of Medicine of the University of Oviedo. Since 1998, after her postdoctoral stage in the Departments of Pharmacology and Biophysics at the Mount Sinai Medical Center in New York, she focused her research on pharmacology applied to drug discovery in multidisciplinary, collaborative, public-private working environments (with more than 30 companies) which has given her important recognition in open innovation in drug discovery.

She is director of the USC Singular Centre, CiMUS, and founding trustee of the Kaertor Foundation, a foundation that leads some of the leading public-private open innovation initiatives in Southern Europe 2023.

Author of 235 scientific articles and more than 300 communications at conferences and director of 26 doctoral theses with the highest marks, she participated in more than 100 competitively funded research projects, 76 as principal investigator and in more than 50 research and transfer contracts, in which 17 new drugs reached clinical trials. The latest was the Rescata COVID Programme for the treatment of COVID-19.

She is inventor of 17 patents (four with licensing/exploitation agreements); co-founder of four biotech companies: Pharmatools Digital Interactive Services, Allelyus, Oncostellae (with two drugs in clinical trials) and Celtarys. Leader of the USC CiMUS EU-OPENSCREEN ERIC high-capacity node. Coordinator of Drug Discovery Networks in Galicia (REGID) and Spain (REDEFAR, ES-OPENSCREEN I and II).

She currently coordinates the Spanish Plan for Biotechnology Applied to Health for Galicia and leads the Drug Screening Action Line for Spain. She coordinates the sub-area of Diagnostic, Prognostic and Therapeutic Tools of the Biomedicine area of the State Research Agency (AEI) in the period 2020 -2023 and is vice-president of the Royal Academy of Pharmacy of Galicia.

She has been included in the international LOréal-Unesco programme "For Women in Science", in the book entitled "Nosotras biocientíficas españolas", and has been selected by EFPIA (European Federation of Pharmaceutical Industries and Associations) among the "30 scientists from 30 countries in Europe" in the Portraits of Science-Scientists of Tomorrow initiative (Paris, 19 June 2008). Maria Josefa Wonenburger Award 2019.

https://ranf.com/sesion/toma-de-posesion-como-academica-correspondiente-de-la-ilma-sra-dna-maria-isabel-loza-garcia/